Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00988533 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
A Phase 1 study, sponsored by Topaz Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00988533 is a Phase 1 study that has completed, run by Topaz Pharmaceuticals. The registered enrollment target is 30 participants.
The verdict
NCT00988533, a Phase 1 study, has completed, sponsored by Topaz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
Interventions
- DRUG 0.5% Ivermectin Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00988533
The ClinicalTrials.gov registry entry for NCT00988533 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topaz Pharmaceuticals, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 0.5% Ivermectin Cream is the first listed.
NCT00988533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00988533 about?
NCT00988533 is a clinical study titled "A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age". The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
What is the current status of trial NCT00988533?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00988533?
The interventions under investigation include: 0.5% Ivermectin Cream (DRUG).
Who is sponsoring clinical trial NCT00988533?
This trial is sponsored by Topaz Pharmaceuticals, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.